Helsinn Advanced Synthesis SA
Helsinn Advanced Synthesis SA (HAS) develops and manufactures Active Pharmaceutical Ingredients (APIs), Advanced Intermediates,High Potency Active Pharmaceutical Ingredients (HPAPIs) and Cytotoxic compounds for third parties under cGMP on an exclusive basis. The production plants, located in Biasca, Switzerland, were first established in1983 and have gone through continuous expansions and renovations to keep up with the latest technology trends. HAS has been successfully approved by the Swiss authorities and by the US FDA (last inspection in April 2014 with no 483s), EMA and Japanese PMDA as well as by several other national boards. HAS is constantly making large investments to increase production capacity and more importantly add new technologies to increase production flexibility.